NO20061659L - Fremgangsmate for fremstilling av plasmid av hoy farmasoytisk kvalitet - Google Patents

Fremgangsmate for fremstilling av plasmid av hoy farmasoytisk kvalitet

Info

Publication number
NO20061659L
NO20061659L NO20061659A NO20061659A NO20061659L NO 20061659 L NO20061659 L NO 20061659L NO 20061659 A NO20061659 A NO 20061659A NO 20061659 A NO20061659 A NO 20061659A NO 20061659 L NO20061659 L NO 20061659L
Authority
NO
Norway
Prior art keywords
order
purification steps
pharmaceutical quality
pdna
continuous
Prior art date
Application number
NO20061659A
Other languages
English (en)
Norwegian (no)
Inventor
Michel Couder
Francis Blanche
Nicolas Maestrali
David Gaillac
Thierry Guillemin
Original Assignee
Centelion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centelion filed Critical Centelion
Publication of NO20061659L publication Critical patent/NO20061659L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/06—Hydrolysis; Cell lysis; Extraction of intracellular or cell wall material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Manufacturing & Machinery (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20061659A 2003-09-17 2006-04-11 Fremgangsmate for fremstilling av plasmid av hoy farmasoytisk kvalitet NO20061659L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50346403P 2003-09-17 2003-09-17
US56300804P 2004-04-19 2004-04-19
PCT/EP2004/011437 WO2005026331A2 (fr) 2003-09-17 2004-09-17 Procede de preparation d'adn plasmide de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
NO20061659L true NO20061659L (no) 2006-06-13

Family

ID=42827706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061659A NO20061659L (no) 2003-09-17 2006-04-11 Fremgangsmate for fremstilling av plasmid av hoy farmasoytisk kvalitet

Country Status (17)

Country Link
US (1) US20070111221A1 (fr)
EP (1) EP1664277B1 (fr)
JP (1) JP2007505613A (fr)
KR (1) KR101094032B1 (fr)
CN (1) CN1882682B (fr)
AT (1) ATE532853T1 (fr)
AU (2) AU2004272748C1 (fr)
BR (1) BRPI0413907A (fr)
CA (1) CA2536931A1 (fr)
EA (1) EA009447B1 (fr)
ES (1) ES2376173T3 (fr)
IL (1) IL174147A0 (fr)
MX (1) MXPA06003004A (fr)
NO (1) NO20061659L (fr)
NZ (1) NZ545449A (fr)
PT (1) PT1664277E (fr)
WO (1) WO2005026331A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ549835A (en) * 2004-04-19 2008-12-24 Centelion Method for purifying plasmid DNA
WO2006060282A2 (fr) * 2004-11-30 2006-06-08 Merial Limited Melangeurs pour chimiolyse de cellules
EP2054498A1 (fr) * 2006-08-15 2009-05-06 Basf Se Procédé permettant d'isoler des protéines des cellules de production
CA2668818C (fr) 2006-10-10 2018-06-26 Xenomics, Inc. Compositions, procedes et trousses pour isoler acides nucleiques a partir de fluides corporels au moyen d'un milieu d'echange anionique
ATE529448T1 (de) 2007-02-28 2011-11-15 Lipoxen Technologies Ltd Verringerung von endotoxin in polysialinsäuren
EP2160459A2 (fr) 2007-05-23 2010-03-10 Nature Technology Corp. Production améliorée d'adn plasmidique de e.coli
PT2153260T (pt) * 2007-05-23 2017-04-24 Vgxi Inc Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma
WO2008150838A1 (fr) * 2007-05-31 2008-12-11 Ge Healthcare Uk Limited Système miniprep amélioré pour une extraction simple et rapide d'adn plasmidique
ES2556711T3 (es) * 2008-04-09 2016-01-19 Viromed Co., Ltd. Formulaciones liofilizadas de ADN para el aumento de la expresión del ADN plasmídico
US20110262442A1 (en) * 2009-11-06 2011-10-27 Adenios, Inc. Compositions for treating cns disorders
RU2488406C1 (ru) * 2012-02-16 2013-07-27 Общество с ограниченной ответственностью "НТфарма" Фармацевтическая композиция для терапии острых токсических состояний
RU2489168C1 (ru) * 2012-02-28 2013-08-10 Общество с ограниченной ответственностью "НТфарма" Фармацевтическая композиция, продуцирующая антиоксидантный, антимикробный, антитоксический белок - лактоферрин человека, способ ее получения и способ терапии
EP2682168A1 (fr) 2012-07-02 2014-01-08 Millipore Corporation Dispositif de tirage et métier à filer
CN104099321A (zh) * 2014-07-10 2014-10-15 广州市军科泰特医药科技有限公司 抗肺癌T-VISA-BikDD质粒的制备方法
US20180036409A1 (en) * 2014-12-29 2018-02-08 Bonac Corporation Composition containing nucleic acid molecule stably
CN106884011B (zh) * 2015-12-16 2020-11-17 固安鼎泰海规生物科技有限公司 一种规模化质粒纯化的联合液相层析分离方法
JP2019514394A (ja) 2016-05-06 2019-06-06 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ プラグフローチューブ型バイオリアクター、それを含むシステム、およびウイルスの調製のための方法
US20210207075A1 (en) * 2018-05-31 2021-07-08 Vgxi Inc. Lysis coil apparatus and uses thereof for isolation and purification of polynucleotides
EP4127163A1 (fr) 2020-03-31 2023-02-08 Richter-Helm Biologics GmbH & Co. KG Procédés de production d'adn plasmidique
CN111394427B (zh) * 2020-04-22 2023-04-11 宁波市博坤生物科技有限公司 一种含泥土检材中微量dna的提取方法
DK3906982T4 (da) 2020-05-08 2025-11-10 Axagarius Gmbh & Co Kg Fremgangsmåde til plasmidrengøring under samtidig reduktion af endotoksiner
JP2021074018A (ja) * 2021-02-12 2021-05-20 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ プラグフローチューブ型バイオリアクター、それを含むシステム、およびウイルスの調製のための方法
CN115404232A (zh) * 2021-05-10 2022-11-29 艾棣维欣(苏州)生物制品有限公司 用于提取细菌中质粒dna的方法
CN115404154A (zh) * 2021-05-10 2022-11-29 艾棣维欣(苏州)生物制品有限公司 用于提取细菌中质粒dna的装置
JP2024519895A (ja) * 2021-05-18 2024-05-21 賽斯尓▲チン▼生物技術（上海）有限公司 細胞を修飾する方法
CN113332869B (zh) * 2021-06-23 2022-12-23 苏州沃美生物有限公司 混合装置和方法以及重组大肠杆菌质粒提取方法
CN120569463A (zh) * 2022-10-19 2025-08-29 Abec公司 细胞裂解和质粒分离系统
CN117187069B (zh) * 2023-09-18 2024-04-05 苏州依科赛生物科技股份有限公司 一种碱裂解工艺的大肠杆菌hcp检测方法
WO2025157970A1 (fr) 2024-01-26 2025-07-31 Richter Biologics Gmbh & Co. Kg Procédés de production d'adn plasmidique à grande échelle
WO2025166642A1 (fr) * 2024-02-07 2025-08-14 首都医科大学 Adn plasmidique à haute bioactivité, sa préparation et son stockage, vaccin, kit et utilisation associé
WO2025252480A1 (fr) 2024-06-07 2025-12-11 F. Hoffmann-La Roche Ag Procédé de purification d'adn plasmidique
JP2026006022A (ja) * 2024-06-28 2026-01-16 キヤノン株式会社 細胞処理方法、及び細胞処理装置

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2692764A (en) * 1951-01-19 1954-10-26 Howe Baker Corp Mixing apparatus
JPS5321458A (en) * 1976-08-11 1978-02-27 Hitachi Ltd Device for mixing fluids
US4737349A (en) * 1985-11-01 1988-04-12 Ciba-Geigy Corporation Tubular reactor for heterogeneous reactions
US5096818A (en) * 1990-06-04 1992-03-17 Autogen Instruments, Inc. Nucleic acid separation method
US5561064A (en) * 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
US6197553B1 (en) * 1994-07-15 2001-03-06 Merck & Co., Inc. Method for large scale plasmid purification
US5837529A (en) * 1994-10-17 1998-11-17 Genzyme Corporation Method for lysing cells
FR2728264B1 (fr) * 1994-12-16 1997-01-31 Rhone Poulenc Rorer Sa Purification d'adn par formation de triple helice avec un oligonucleotide immobilise
US5840254A (en) * 1995-06-02 1998-11-24 Cdc Technologies, Inc. Apparatus for mixing fluids for analysis
AU706857B2 (en) * 1995-12-21 1999-06-24 Genzyme Corporation Method for lysing cells
FR2746412B1 (fr) * 1996-03-21 1998-06-12 Rhone Poulenc Rorer Sa Purification d'adn plasmidique de qualite pharmaceutique
US7026468B2 (en) * 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) * 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US5721120A (en) * 1996-10-02 1998-02-24 Merck & Co., Inc. Method of disrupting cultured cells using an impinging jet device
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
GB2338236B (en) * 1998-06-13 2003-04-09 Aea Technology Plc Microbiological cell processing
US6664049B1 (en) * 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
IL146695A0 (en) * 1999-05-28 2002-07-25 Bio Science Contract Productio Methods of dna purification and purified dna
WO2001025482A1 (fr) * 1999-10-02 2001-04-12 Bioneer Corporation Appareil de purification d'adn automatique
US7011791B2 (en) * 2000-09-18 2006-03-14 University Of Washington Microfluidic devices for rotational manipulation of the fluidic interface between multiple flow streams
WO2004024283A2 (fr) * 2002-09-13 2004-03-25 Valentis, Inc. Appareil et procede de purification a l'echelle de la chimie preparatoire d'acides nucleiques
ATE420167T1 (de) * 2002-12-23 2009-01-15 Vical Inc Reinigungsverfahren für plasmid-dna

Also Published As

Publication number Publication date
KR20060086941A (ko) 2006-08-01
AU2004272748C1 (en) 2010-07-08
CN1882682B (zh) 2010-06-16
NZ545449A (en) 2009-07-31
CA2536931A1 (fr) 2005-03-24
EP1664277A2 (fr) 2006-06-07
US20070111221A1 (en) 2007-05-17
AU2004272748A1 (en) 2005-03-24
ES2376173T3 (es) 2012-03-09
CN1882682A (zh) 2006-12-20
IL174147A0 (en) 2006-08-01
WO2005026331A3 (fr) 2005-11-17
EA200600579A1 (ru) 2006-10-27
WO2005026331A2 (fr) 2005-03-24
AU2004272748B2 (en) 2009-12-03
MXPA06003004A (es) 2006-06-23
JP2007505613A (ja) 2007-03-15
BRPI0413907A (pt) 2006-10-24
EP1664277B1 (fr) 2011-11-09
AU2010200801A1 (en) 2010-03-25
PT1664277E (pt) 2012-01-17
KR101094032B1 (ko) 2011-12-19
EA009447B1 (ru) 2007-12-28
ATE532853T1 (de) 2011-11-15
HK1096994A1 (en) 2007-06-15

Similar Documents

Publication Publication Date Title
NO20061659L (no) Fremgangsmate for fremstilling av plasmid av hoy farmasoytisk kvalitet
ATE496990T1 (de) Verfahren zur herstellung von plasmid dns in pharmazeutischer qualität
WO2005063820A3 (fr) Proteines de fusion de il-7
GB2575930A (en) Nucleobase editors comprising nucleic acid programmable DNA binding proteins
WO2005059097A3 (fr) Procedes de production a fidelite elevee de longues molecules d'acide nucleique
MX2007006946A (es) Aislado de proteina de soya y proceso para su manufactura.
WO2004024757A3 (fr) Molecules pna modifiées
WO2006127899A3 (fr) Synthese de (r)-n-methylnaltrexone
EP4559926A3 (fr) Procédés de filtration de virus
WO2003097810A3 (fr) Nitrilases, acides nucleiques les codant et leurs procedes de production et d'utilisation
WO2011090720A3 (fr) Purification des protéines
SG144906A1 (en) Sushi peptide multimer
CY1111401T1 (el) Μεθοδος καθαρισμου πλασμιδιακου dna
WO2004081166A3 (fr) Sequences de nucleotides de bacteries de forme coryneenne codant des proteines intervenant dans le metabolisme de la l-serine et procedes de production de l-serine
WO2006047728A3 (fr) Genes bmp et proteines de fusion
WO2005023979A3 (fr) Molecules d'acide nucleique de s. mansoni isolees et utilisations associees
WO2003014359A3 (fr) Proteine hybride
WO2005072092A3 (fr) Systemes d'expression genique a regulation stricte
WO2010083225A3 (fr) Biocides dirigés contre cryptosporidium
WO2006055040A3 (fr) Identification de proteines dans un genome
WO2006009938A3 (fr) Gomme gellane genetiquement purifiee
EP1350849A3 (fr) Méthode de clonage et d'expression de l'endonucléase de réstriction Bsal et de la méthylase Bsal dans E. coli
WO2004016786A3 (fr) Produit recombine d'expression d'adn pour l'expression genique multiple
WO2020140021A3 (fr) Procédé de production, d'isolement et de purification de protéines recombinantes modifiées
MXPA05013389A (es) Purificacion de variantes her-2.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application